Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements...
As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data.
is approaching multi-year highs...
The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult...
Biotech, short for biotechnology, is an industry responsible for making life-saving and life-changing drugs. The industry, having made a name for itself with the...